This In-house course has been designed to give practical advice and guidance on how to successfully develop market approval in the EU. The programme will take participants through a step-by-step approach to the process and will also provide key guidance on how to maintain MA once achieved.
This In-house course has been designed to give practical advice and guidance on how to successfully develop a veterinary vaccine and achieve market approval in the EU. The programme will take participants through a step-by-step approach to the process. The workshop will assist delegates to gain a better understanding of the requirements in practice. There will be ample time for discussion during the two days.
Your next step is to call us now on +44 (0)20 7749 4730 or email us at email@example.com or use our contact form and find out how we can help. There are no commitments, and if we cannot help our advice and recommendations are free of charge.
A Practical Guide of EU Regulatory Framework for Veterinary Vaccines
Using SPCs as a Tool for Development
Planning a Vaccine Development – Workshop
Workshop – Groups Report Back and Q&A
Seeking Regulatory Advice During Planning and Development of Novel Vaccines
Procedures Aimed at Promoting Innovation
Preparing the Dossier Submission
European Licensing Procedures and Regulatory Strategy
Juliet Greenslade has over 16 years experience working in the Animal Health Industry and holds degrees in Immunology and Medical Microbiology. Having started out as a Medical Microbiologist in a large teaching hospital she moved into the Animal Health arena. Juliet had been working as a Scientist and GLP study Director in Biologicals R&D at Intervet for over 6 years when she developed a keen interest in Regulatory Affairs. That led her to join Schering-Plough where she took a position of a Senior Regulatory Manager and then Pfizer (now Zoetis) as an Associate Director. Juliet’s vast experience in “big pharma” includes developing and registering new products, life-cycle maintenance of existing products and advising on regulatory strategy. In her current role as a Project Manager of Biologicals Regulatory Affairs at Triveritas she assists clients in a variety of areas, from advising on regulatory strategy and product development, through to preparing Expert Reports, writing Dossiers and running regulatory procedures on behalf of clients.
Mel Munro has been working in regulatory affairs in the Animal Health Industry since 2002. She has been involved in all aspects of veterinary vaccine development and spends most of her time assisting clients with Start-to-Finish projects, taking ideas for veterinary medicines from proof of concept right through to Marketing Authorisations (MA). On a daily basis she is responsible for preparing reports, documents and Dossiers for MA submissions, and for running National, Decentralised and Centralised Procedures. She also provides gap analysis of existing products and strategic advice on new product developments. Over her career she has been involved in various vaccine development projects ranging from inactivated and live viral and bacterial vaccines, to novel vaccines that include products of rDNA technology and GMO’s.